An FTO inhibitor, rehein, can restore TKI sensitivity.428 Moreover, FTO can enhance FLT3-ITD expression to promote acute promyelocytic leukemia (APL) cell survival and proliferation. Here, FLT3 is linked to acute promyelocytic leukemia.